Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
328.3 INR | +0.14% | -0.21% | -19.13% |
Mar. 19 | Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs | MT |
Mar. 08 | Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products | MT |
Sales 2022 | 5.99B 71.8M | Sales 2023 | 5.56B 66.63M | Capitalization | 2.16B 25.96M |
---|---|---|---|---|---|
Net income 2022 | 407M 4.88M | Net income 2023 | 266M 3.19M | EV / Sales 2022 | 0.6 x |
Net cash position 2022 | 4.11M 49.25K | Net cash position 2023 | 291M 3.48M | EV / Sales 2023 | 0.34 x |
P/E ratio 2022 |
8.71
x | P/E ratio 2023 |
8.15
x | Employees | 998 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 52.79% |
1 day | +0.14% | ||
1 week | -0.21% | ||
Current month | +0.58% | ||
1 month | +7.67% | ||
3 months | -12.42% | ||
6 months | +20.70% | ||
Current year | -19.13% |
Managers | Title | Age | Since |
---|---|---|---|
Ashutosh Jain
CEO | Chief Executive Officer | 46 | 07-04-30 |
Pawan Chaudhary
CHM | Chairman | 59 | 89-09-14 |
Jitendra Singh
ADM | Chief Administrative Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilbert Wenzel
BRD | Director/Board Member | 67 | - |
Peeyush Jain
BRD | Director/Board Member | 52 | - |
Ashutosh Jain
CEO | Chief Executive Officer | 46 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 328.3 | +0.14% | 1,500 |
24-04-25 | 327.8 | -0.65% | 2,847 |
24-04-24 | 330 | -0.23% | 3,314 |
24-04-23 | 330.8 | -0.91% | 1,531 |
24-04-22 | 333.8 | +1.46% | 3,942 |
Delayed Quote Bombay S.E., April 26, 2024 at 06:16 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.13% | 52.62M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- VENUSREM Stock